Great Diamond Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $992K | Buy |
14,375
+9,010
| +168% | +$622K | 0.21% | 109 |
|
|
2025
Q1 | $373K | Sell |
5,365
-24,739
| -82% | -$1.72M | 0.1% | 126 |
|
|
2024
Q4 | $2.59M | Sell |
30,104
-157
| -0.5% | -$13.5K | 0.67% | 42 |
|
|
2024
Q3 | $3.6M | Sell |
30,261
-6,279
| -17% | -$748K | 0.92% | 28 |
|
|
2024
Q2 | $5.22M | Sell |
36,540
-96
| -0.3% | -$13.7K | 1.23% | 20 |
|
|
2024
Q1 | $4.7M | Buy |
36,636
+3,792
| +12% | +$487K | 1.08% | 22 |
|
|
2023
Q4 | $3.4M | Sell |
32,844
-732
| -2% | -$75.7K | 0.84% | 28 |
|
|
2023
Q3 | $3.05M | Buy |
33,576
+242
| +0.7% | +$22K | 0.83% | 32 |
|
|
2023
Q2 | $2.7M | Buy |
33,334
+13,832
| +71% | +$1.12M | 0.71% | 35 |
|
|
2023
Q1 | $1.55M | Sell |
19,502
-1,524
| -7% | -$121K | 0.45% | 56 |
|
|
2022
Q4 | $1.42M | Buy |
21,026
+784
| +4% | +$53.1K | 0.44% | 57 |
|
|
2022
Q3 | $1.01M | Buy |
20,242
+10,430
| +106% | +$519K | 0.34% | 69 |
|
|
2022
Q2 | $546K | Buy |
9,812
+618
| +7% | +$34.4K | 0.18% | 106 |
|
|
2022
Q1 | $510K | Buy |
9,194
+3,584
| +64% | +$199K | 0.14% | 125 |
|
|
2021
Q4 | $314K | Buy |
5,610
+218
| +4% | +$12.2K | 0.08% | 172 |
|
|
2021
Q3 | $258K | Buy |
5,392
+582
| +12% | +$27.8K | 0.07% | 180 |
|
|
2021
Q2 | $201K | Buy |
+4,810
| New | +$201K | 0.06% | 194 |
|
|
2020
Q2 | – | Sell |
-12,460
| Closed | -$375K | – | 153 |
|
|
2020
Q1 | $375K | Sell |
12,460
-3,638
| -23% | -$109K | 0.19% | 79 |
|
|
2019
Q4 | $465K | Buy |
+16,098
| New | +$465K | 0.18% | 83 |
|